Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin

Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test

NCT04074980 ·Status: COMPLETED ·Phase: NA

International Normalised Ratio Evaluation by Generalist Practitioners in Full-time Care Establishments for the Elderly

NCT02614573 ·Status: COMPLETED ·Phase: NA

NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers

NCT03666650 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

NCT02376803 ·Status: COMPLETED ·Phase: PHASE4

Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy

NCT01474460 ·Status: COMPLETED ·Phase: NA

Assessing the Ability of Warfarin Treated Patients to Predict Their INR

NCT02764112 ·Status: COMPLETED

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

NCT04117048 ·Status: COMPLETED ·Phase: NA

Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

NCT01375725 ·Status: COMPLETED

Long Study - Longitudinal Thrombosis in End Stage Renal Disease

NCT00157664 ·Status: UNKNOWN

Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer

NCT03180567 ·Status: UNKNOWN ·Phase: NA

Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

NCT00157651 ·Status: COMPLETED ·Phase: PHASE3

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

NCT00334464 ·Status: COMPLETED ·Phase: NA

A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

NCT01400646 ·Status: COMPLETED ·Phase: PHASE1

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation

NCT05205863 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Blood Donation From Warfarin Users for the Development of POC INR Monitor

NCT02355730 ·Status: UNKNOWN ·Phase: NA

Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service

NCT02392104 ·Status: COMPLETED ·Phase: NA

PT/INR Reference Interval IN Healthy Volunteers

NCT02319109 ·Status: COMPLETED

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

NCT03064035 ·Status: COMPLETED ·Phase: PHASE4

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

NCT00830570 ·Status: COMPLETED

Anticoagulant Clinics and Vitamin K Antagonists

NCT00966290 ·Status: COMPLETED ·Phase: PHASE4

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

NCT05926518 ·Status: COMPLETED

Low INR to Minimize Bleeding With Mechanical Valves Trial

NCT03636295 ·Status: RECRUITING ·Phase: PHASE3

Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)

NCT00634907 ·Status: COMPLETED ·Phase: NA

PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

NCT00005684 ·Status: COMPLETED